Back to Search
Start Over
Urolithiasis in HIV-positive patients treated with atazanavir.
- Source :
-
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2007 Oct 15; Vol. 45 (8), pp. e105-8. Date of Electronic Publication: 2007 Sep 12. - Publication Year :
- 2007
-
Abstract
- Among protease inhibitors, atazanavir has not been associated with urolithiasis in clinical studies. We describe 11 cases of atazanavir-associated urolithiasis in patients with human immunodeficiency virus (HIV) infection. Patients with low water intake, high urinary pH, and a prior history of urinary stones may have a higher risk of atazanavir-associated urine crystallization.
- Subjects :
- Adult
Atazanavir Sulfate
Female
HIV Protease Inhibitors therapeutic use
Humans
Hydrogen-Ion Concentration
Male
Middle Aged
Oligopeptides therapeutic use
Pyridines therapeutic use
Risk Factors
Urine chemistry
Water metabolism
HIV Infections complications
HIV Infections drug therapy
HIV Protease Inhibitors adverse effects
Oligopeptides adverse effects
Pyridines adverse effects
Urolithiasis chemically induced
Subjects
Details
- Language :
- English
- ISSN :
- 1537-6591
- Volume :
- 45
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Publication Type :
- Academic Journal
- Accession number :
- 17879904
- Full Text :
- https://doi.org/10.1086/521930